NuCana plc (NCNA) stock
NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.86−0.07 (-7.19%)
Close on Nov 16, 2026Market cap $3.59MP/E –Yield –
NuCana total assets
Total assets on the balance sheet at the end of each period.
NuCana's total assets was £25.78M at Jun 30, 2026. For fiscal 2025 it was £29.83M, up 101.9% from the year before. The highest annual figure on record is £107.79M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | £29.83M | +101.9% |
| FY2024 | Dec 31, 2024 | £14.77M | -46.9% |
| FY2023 | Dec 31, 2023 | £27.81M | -52.3% |
| FY2022 | Dec 31, 2022 | £58.25M | -24.8% |
| FY2021 | Dec 31, 2021 | £77.47M | -28.1% |
| FY2020 | Dec 31, 2020 | £107.79M | +53.4% |
| FY2019 | Dec 31, 2019 | £70.27M | -19.4% |
| FY2018 | Dec 31, 2018 | £87.19M | -9.5% |
| FY2017 | Dec 31, 2017 | £96.36M | +254.1% |
| FY2016 | Dec 31, 2016 | £27.21M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | £25.78M | +28.5% |
| Q4 FY2025 | Dec 31, 2025 | £29.83M | +7.3% |
| Q2 FY2025 | Jun 30, 2025 | £16.22M | -60.7% |
| Q4 FY2024 | Dec 31, 2024 | £14.77M | -74.6% |
| Q2 FY2024 | Jun 30, 2024 | £20.07M | -69.9% |
| Q4 FY2023 | Dec 31, 2023 | £27.81M | -64.1% |
| Q2 FY2023 | Jun 30, 2023 | £41.26M | -54.0% |
| Q4 FY2022 | Dec 31, 2022 | £58.25M | -36.9% |
| Q2 FY2022 | Jun 30, 2022 | £66.63M | -33.9% |
| Q4 FY2021 | Dec 31, 2021 | £77.47M | -28.1% |
| Q3 FY2021 | Sep 30, 2021 | £89.79M | -25.1% |
| Q2 FY2021 | Jun 30, 2021 | £92.32M | +44.0% |
| Q1 FY2021 | Mar 31, 2021 | £100.87M | +50.6% |
| Q4 FY2020 | Dec 31, 2020 | £107.79M | +53.4% |
| Q3 FY2020 | Sep 30, 2020 | £119.88M | +57.9% |
| Q2 FY2020 | Jun 30, 2020 | £64.10M | -19.9% |
| Q1 FY2020 | Mar 31, 2020 | £67.00M | -18.5% |
| Q4 FY2019 | Dec 31, 2019 | £70.27M | -19.4% |
| Q3 FY2019 | Sep 30, 2019 | £75.94M | -15.7% |
| Q2 FY2019 | Jun 30, 2019 | £79.99M | -12.0% |
| Q1 FY2019 | Mar 31, 2019 | £82.23M | -14.7% |
| Q4 FY2018 | Dec 31, 2018 | £87.19M | +220.4% |
| Q3 FY2018 | Sep 30, 2018 | £90.10M | – |
| Q2 FY2018 | Jun 30, 2018 | £90.88M | – |
| Q4 FY2017 | Dec 31, 2017 | £96.36M | – |
| Q4 FY2016 | Dec 31, 2016 | £27.21M | – |
See a number that looks wrong?